Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CHLORPROMAZINE Cause Product prescribing issue? 6 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product prescribing issue have been filed in association with CHLORPROMAZINE (Chlorpromazine). This represents 0.2% of all adverse event reports for CHLORPROMAZINE.

6
Reports of Product prescribing issue with CHLORPROMAZINE
0.2%
of all CHLORPROMAZINE reports
5
Deaths
0
Hospitalizations

How Dangerous Is Product prescribing issue From CHLORPROMAZINE?

Of the 6 reports, 5 (83.3%) resulted in death.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CHLORPROMAZINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CHLORPROMAZINE Cause?

Drug ineffective (374) Toxicity to various agents (301) Off label use (288) Drug abuse (243) Overdose (223) Foetal exposure during pregnancy (190) Neuroleptic malignant syndrome (186) Somnolence (170) Neutropenia (169) Seizure (164)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which CHLORPROMAZINE Alternatives Have Lower Product prescribing issue Risk?

CHLORPROMAZINE vs CHLORPROTHIXENE CHLORPROMAZINE vs CHLORTHALIDONE CHLORPROMAZINE vs CHLORZOXAZONE CHLORPROMAZINE vs CHOLECALCIFEROL CHLORPROMAZINE vs CHOLECALCIFEROL\ERGOCALCIFEROL

Related Pages

CHLORPROMAZINE Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue CHLORPROMAZINE Demographics